Roberto Badagliacca

Pubblicazioni

Titolo Pubblicato in Anno
Biobanks: The unmet need in heart failure management VASCULAR PHARMACOLOGY 2023
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension CURRENT HEART FAILURE REPORTS 2023
Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility JOURNAL OF CLINICAL MEDICINE 2023
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the KATP Channel INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension ERJ OPEN RESEARCH 2023
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension GENETICS IN MEDICINE 2023
Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best? CHEST 2023
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients CURRENT HEART FAILURE REPORTS 2023
A Meta-Analysis of Short-Term Outcomes of TAVR versus SAVR in Bicuspid Aortic Valve Stenosis and TAVR Results in Different Bicuspid Valve Anatomies JOURNAL OF CLINICAL MEDICINE 2023
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing JOURNAL OF CLINICAL MEDICINE 2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis INTERNATIONAL JOURNAL OF CARDIOLOGY 2023
New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events JOURNAL OF CLINICAL MEDICINE 2023
Exploratory study on the endogenous ouabain in idiopathic pulmonary arterial hypertension patients ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ 2023
Heart failure patients with improved ejection fraction: Insights from the MECKI score database EUROPEAN JOURNAL OF HEART FAILURE 2023
Real‐world evidence to advance knowledge in pulmonary hypertension. status, challenges, and opportunities. a consensus statement from the pulmonary vascular research institute's innovative drug development initiative's real‐world evidence working group PULMONARY CIRCULATION 2023
IABP versus impella support in cardiogenic shock. “in silico” study JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE 2023
Modelling and simulation of the combined use of IABP and impella as a rescue procedure in cardiogenic shock. an alternative for non-transplant centres BIOENGINEERING 2023
Exploring theprognostic performance of MECKI score in heart failure patients with non-valvular atrial fibrillation treated with edoxaban JOURNAL OF CLINICAL MEDICINE 2023
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension JOURNAL OF CLINICAL MEDICINE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma